Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2024
Same journal

[Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?]

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

[Tixagevimab-cilgavimab as pre-exposure prophylactic treatment against SARS-CoV-2 in kidney transplantation patients].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

[Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: Renal replacement therapy and mortality. FRA-COVID SEN Registry Data].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

Acute interstitial nephritis following COVID-19 vaccination.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2023
Same journal

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2022

Related Experiment Videos

[Updates in hemodialysis].

Maria D Arenas Jiménez1

  • 1Jefe del Servicio de Nefrologia, Hospital Perpetuo Socorro, Alicante, Spain.

Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|October 14, 2008
PubMed
Summary

Nephrologists aim to reduce patient mortality by identifying high-risk individuals. Cardiovascular disease, driven by oxidative stress and inflammation in chronic kidney disease patients, is a key concern, alongside quality management systems.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Clinical Quality Management

Context:

  • Chronic kidney disease (CKD) patients face high morbidity and mortality.
  • Cardiovascular disease (CVD) is a primary cause of death in CKD.
  • Nontraditional CVD risk factors like oxidative stress, inflammation, and endothelial dysfunction are increasingly recognized.

Purpose:

  • To explore markers for identifying high-risk CKD patients.
  • To understand the role of oxidative stress, inflammation, and endothelial dysfunction in CKD-related CVD.
  • To investigate the impact of quality management systems on clinical outcomes in nephrology.

Summary:

  • CKD patients have elevated cardiovascular risk due to factors including oxidative stress, inflammation, and endothelial dysfunction.

Related Experiment Videos

  • Quality management systems are gaining traction in clinical practice.
  • Work processes within healthcare centers may significantly influence patient outcomes.

    • Impact:

    • Improved identification of CKD patients at risk for cardiovascular events.
    • Potential for enhanced clinical practice through quality management integration.
    • Better understanding of multifactorial risks in CKD patients.